Syndax Pharmaceuticals Inc. (SNDX) NASDAQ
$23.76 0.69 (2.99%)
Market Cap: $1.96B
As of 03/28/24 03:59 PM EDT. Market closed.
Syndax Pharmaceuticals Inc. (SNDX)
NASDAQ
$23.76
0.69 (2.99%)
Market Cap: $1.96B
As of 03/28/24 03:59 PM EDT. Market closed.
Add to Portfolio
syndax pharmaceuticals is a biotechnology company located at 35 gatehouse dr., building d, floor 3, waltham, ma ... read more
syndax pharmaceuticals is a biotechnology company located at 35 gatehouse dr., building d, floor 3, waltham, ma 02451. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Briggs Morrison
Full Time Employees
112
CEO Compensation (Base)
$566,073
CEO Compensation (Total)
$2.08M
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Briggs Morrison
Full Time Employees
112
CEO Compensation (Base)
$566,073
CEO Compensation (Total)
$2.08M
URL
Address
Building D, 35 Gatehouse Dr Fl 3, Massachusetts, Waltham, 02451-1215.
PRICE CHART FOR SYNDAX PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$23.25
Previous Close
$23.07
Days Range
$21.79 - $23.25
52 week range
$11.22 - $25.34
Volume
1,058,374
Avg. Volume (30 days)
1,330,426
Market Cap
$1.96B
Dividend Yield
-
P/E
(140.55)
Shares Outstanding
84,965,486
Open
$23.25
Previous Close
$23.07
Days Range
$21.79 - $23.25
52 week range
$11.22 - $25.34
Volume
1,058,374
Avg. Volume (30 days)
1,330,426
Market Cap
$1.96B
Dividend Yield
-
P/E
(140.55)
Shares Outstanding
84,965,486
FINANCIAL STATEMENTS FOR SYNDAX PHARMACEUTICALS INC
LOADING...
INSIDER TRANSACTIONS FOR SYNDAX PHARMACEUTICALS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Goldan Keith A. | Chief Financial Officer | Jan 31, 2024 | Option Exercise | $17.42 | 1,183 | 20,608 | 4,673 | Feb 09, 2024, 04:05 PM |
Goldan Keith A. | Chief Financial Officer | Jul 31, 2023 | Option Exercise | $18.12 | 862 | 15,619 | 3,490 | Feb 09, 2024, 04:05 PM |
Morrison Briggs | Director | Aug 09, 2023 | Option Exercise | $8.77 | 52,855 | 463,538 | 70,691 | Aug 10, 2023, 06:50 AM |
Morrison Briggs | Director | Aug 09, 2023 | Sale | $18.27 | 52,855 | 965,402 | 17,836 | Aug 10, 2023, 06:50 AM |
Meury William | Director | Aug 02, 2023 | Option Exercise | $8.02 | 83,000 | 665,250 | 83,000 | Aug 03, 2023, 09:12 AM |
Meury William | Director | Aug 02, 2023 | Sale | $20.46 | 83,000 | 1,697,810 | 48,000 | Aug 03, 2023, 09:12 AM |
Morrison Briggs | Director | Jul 10, 2023 | Option Exercise | $8.77 | 52,855 | 463,538 | 70,691 | Jul 11, 2023, 09:23 AM |
Morrison Briggs | Director | Jul 10, 2023 | Sale | $20.40 | 52,855 | 1,078,068 | 17,836 | Jul 11, 2023, 09:23 AM |
Goldan Keith A. | Chief Financial Officer | Jun 13, 2023 | Sale | $22.31 | 577 | 12,873 | 2,628 | Jun 14, 2023, 04:20 PM |
Morrison Briggs | Director | Jun 09, 2023 | Option Exercise | $7.66 | 52,855 | 404,787 | 70,691 | Jun 09, 2023, 05:32 PM |
Morrison Briggs | Director | Jun 09, 2023 | Sale | $21.18 | 52,855 | 1,119,421 | 46,109 | Jun 09, 2023, 05:32 PM |
Morrison Briggs | Director | May 09, 2023 | Option Exercise | $6.38 | 52,855 | 337,215 | 70,691 | May 10, 2023, 04:11 PM |
Morrison Briggs | Director | May 09, 2023 | Sale | $21.41 | 52,855 | 1,131,478 | 17,836 | May 10, 2023, 04:11 PM |
Morrison Briggs | Director | Apr 10, 2023 | Option Exercise | $6.38 | 52,855 | 337,215 | 70,691 | Apr 12, 2023, 04:03 PM |
Morrison Briggs | Director | Apr 10, 2023 | Sale | $19.53 | 52,855 | 1,032,237 | 17,836 | Apr 12, 2023, 04:03 PM |
Morrison Briggs | President, Head of R&D | Mar 13, 2023 | Option Exercise | $6.38 | 52,854 | 337,209 | 70,690 | Mar 14, 2023, 04:42 PM |
Morrison Briggs | President, Head of R&D | Mar 13, 2023 | Sale | $22.53 | 52,854 | 1,190,674 | 17,836 | Mar 14, 2023, 04:42 PM |
Ordentlich Peter | Chief Scientific Officer | Feb 15, 2023 | Option Exercise | $6.95 | 25,000 | 173,791 | 17,428 | Feb 17, 2023, 06:09 PM |
Ordentlich Peter | Chief Scientific Officer | Feb 15, 2023 | Sale | $25.84 | 25,000 | 646,093 | 0 | Feb 17, 2023, 06:09 PM |
Metzger Michael A | Chief Executive Officer | Feb 06, 2023 | Option Exercise | $6.38 | 5,959 | 38,018 | 23,618 | Feb 08, 2023, 04:49 PM |
Metzger Michael A | Chief Executive Officer | Feb 06, 2023 | Sale | $27.64 | 5,959 | 164,697 | 17,659 | Feb 08, 2023, 04:49 PM |
Morrison Briggs | President, Head of R&D | Feb 06, 2023 | Option Exercise | $6.38 | 52,854 | 337,209 | 70,690 | Feb 08, 2023, 04:49 PM |
Morrison Briggs | President, Head of R&D | Feb 06, 2023 | Sale | $26.83 | 52,854 | 1,417,909 | 17,836 | Feb 08, 2023, 04:49 PM |
Ordentlich Peter | Chief Scientific Officer | Jan 31, 2023 | Option Exercise | $17.32 | 69 | 1,195 | 69 | Feb 03, 2023, 04:59 PM |
Ordentlich Peter | Chief Scientific Officer | Feb 01, 2023 | Sale | $28.43 | 69 | 1,962 | 0 | Feb 03, 2023, 04:59 PM |
Legault Pierre | Director | Jan 13, 2023 | Option Exercise | $13.58 | 15,000 | 203,700 | 42,000 | Jan 13, 2023, 04:44 PM |
Legault Pierre | Director | Jan 12, 2023 | Option Exercise | $9.47 | 24,000 | 227,280 | 56,000 | Jan 13, 2023, 04:44 PM |
Legault Pierre | Director | Jan 13, 2023 | Sale | $27.00 | 15,000 | 405,000 | 32,000 | Jan 13, 2023, 04:44 PM |
Legault Pierre | Director | Jan 12, 2023 | Sale | $26.74 | 24,000 | 641,782 | 32,000 | Jan 13, 2023, 04:44 PM |
Ordentlich Peter | Chief Scientific Officer | Dec 02, 2022 | Option Exercise | $6.38 | 17,200 | 109,736 | 17,465 | Dec 02, 2022, 05:01 PM |
Ordentlich Peter | Chief Scientific Officer | Dec 01, 2022 | Option Exercise | $6.37 | 7,800 | 49,651 | 4,293 | Dec 02, 2022, 05:01 PM |
Ordentlich Peter | Chief Scientific Officer | Dec 02, 2022 | Sale | $25.05 | 17,200 | 430,936 | 265 | Dec 02, 2022, 05:01 PM |
Ordentlich Peter | Chief Scientific Officer | Dec 01, 2022 | Sale | $25.01 | 7,800 | 195,089 | 265 | Dec 02, 2022, 05:01 PM |
Katkin Keith | Director | Oct 06, 2022 | Option Exercise | $8.20 | 29,899 | 245,177 | 52,782 | Oct 07, 2022, 04:05 PM |
Katkin Keith | Director | Oct 06, 2022 | Sale | $25.90 | 29,899 | 774,411 | 32,000 | Oct 07, 2022, 04:05 PM |
Metzger Michael A | Chief Executive Officer | Oct 06, 2022 | Option Exercise | $8.77 | 16,231 | 142,346 | 33,890 | Oct 07, 2022, 04:05 PM |
Metzger Michael A | Chief Executive Officer | Oct 06, 2022 | Sale | $25.29 | 16,231 | 410,508 | 17,659 | Oct 07, 2022, 04:05 PM |
Metzger Michael A | Chief Executive Officer | Oct 04, 2022 | Option Exercise | $8.77 | 1,280 | 11,226 | 18,939 | Oct 04, 2022, 05:49 PM |
Metzger Michael A | Chief Executive Officer | Oct 03, 2022 | Option Exercise | $8.77 | 2,883 | 25,284 | 20,542 | Oct 04, 2022, 05:49 PM |
Metzger Michael A | Chief Executive Officer | Sep 30, 2022 | Option Exercise | $8.77 | 29,606 | 259,645 | 47,265 | Oct 04, 2022, 05:49 PM |
Metzger Michael A | Chief Executive Officer | Oct 04, 2022 | Sale | $25.02 | 1,280 | 32,026 | 17,659 | Oct 04, 2022, 05:49 PM |
Metzger Michael A | Chief Executive Officer | Oct 03, 2022 | Sale | $25.01 | 2,883 | 72,107 | 17,659 | Oct 04, 2022, 05:49 PM |
Metzger Michael A | Chief Executive Officer | Sep 30, 2022 | Sale | $25.02 | 29,606 | 740,757 | 17,659 | Oct 04, 2022, 05:49 PM |
Katkin Keith | Director | Oct 04, 2022 | Option Exercise | $8.53 | 360 | 3,071 | 32,223 | Oct 04, 2022, 05:49 PM |
Katkin Keith | Director | Oct 03, 2022 | Option Exercise | $7.96 | 180 | 1,432 | 32,167 | Oct 04, 2022, 05:49 PM |
Katkin Keith | Director | Sep 30, 2022 | Option Exercise | $8.07 | 3,561 | 28,740 | 34,914 | Oct 04, 2022, 05:49 PM |
Katkin Keith | Director | Oct 04, 2022 | Sale | $25.00 | 360 | 9,000 | 32,000 | Oct 04, 2022, 05:49 PM |
Katkin Keith | Director | Oct 03, 2022 | Sale | $25.00 | 180 | 4,500 | 32,000 | Oct 04, 2022, 05:49 PM |
Katkin Keith | Director | Sep 30, 2022 | Sale | $25.07 | 3,561 | 89,277 | 32,000 | Oct 04, 2022, 05:49 PM |
Morrison Briggs | President, Head of R&D | Sep 20, 2022 | Option Exercise | $10.90 | 59,649 | 650,174 | 77,485 | Sep 21, 2022, 04:18 PM |
Morrison Briggs | President, Head of R&D | Sep 19, 2022 | Option Exercise | $10.90 | 114,339 | 1,246,295 | 132,175 | Sep 21, 2022, 04:18 PM |
Morrison Briggs | President, Head of R&D | Sep 20, 2022 | Sale | $23.25 | 59,649 | 1,387,012 | 17,836 | Sep 21, 2022, 04:18 PM |
Morrison Briggs | President, Head of R&D | Sep 19, 2022 | Sale | $23.03 | 114,339 | 2,633,044 | 17,836 | Sep 21, 2022, 04:18 PM |
Morrison Briggs | President, Head of R&D | Sep 14, 2022 | Option Exercise | $7.20 | 87,645 | 631,044 | 105,481 | Sep 16, 2022, 05:34 PM |
Morrison Briggs | President, Head of R&D | Sep 16, 2022 | Option Exercise | $8.77 | 125,000 | 1,096,226 | 89,802 | Sep 16, 2022, 05:34 PM |
Morrison Briggs | President, Head of R&D | Sep 15, 2022 | Option Exercise | $7.20 | 66,775 | 480,780 | 84,611 | Sep 16, 2022, 05:34 PM |
Morrison Briggs | President, Head of R&D | Sep 16, 2022 | Sale | $23.22 | 125,000 | 2,902,437 | 17,836 | Sep 16, 2022, 05:34 PM |
Morrison Briggs | President, Head of R&D | Sep 15, 2022 | Sale | $24.20 | 66,775 | 1,616,035 | 17,836 | Sep 16, 2022, 05:34 PM |
Morrison Briggs | President, Head of R&D | Sep 14, 2022 | Sale | $23.80 | 87,645 | 2,085,855 | 17,836 | Sep 16, 2022, 05:34 PM |
Podlesak Dennis | Director | Sep 15, 2022 | Option Exercise | $6.32 | 66,840 | 422,429 | 142,603 | Sep 16, 2022, 05:34 PM |
Podlesak Dennis | Director | Sep 16, 2022 | Option Exercise | $6.34 | 11,975 | 75,879 | 82,319 | Sep 16, 2022, 05:34 PM |
Podlesak Dennis | Director | Sep 16, 2022 | Sale | $23.43 | 11,975 | 280,607 | 75,763 | Sep 16, 2022, 05:34 PM |
Podlesak Dennis | Director | Sep 15, 2022 | Sale | $24.20 | 66,840 | 1,617,381 | 75,763 | Sep 16, 2022, 05:34 PM |
Ordentlich Peter | Chief Scientific Officer | Jul 29, 2022 | Option Exercise | $14.12 | 265 | 3,742 | 265 | Aug 26, 2022, 04:14 PM |
Ordentlich Peter | Chief Scientific Officer | Aug 24, 2022 | Option Exercise | $6.32 | 25,000 | 158,065 | 23,111 | Aug 26, 2022, 04:14 PM |
Ordentlich Peter | Chief Scientific Officer | Aug 24, 2022 | Sale | $25.04 | 25,000 | 625,892 | 265 | Aug 26, 2022, 04:14 PM |
Legault Pierre | Director | Aug 05, 2022 | Option Exercise | $9.22 | 24,000 | 221,320 | 46,000 | Aug 09, 2022, 04:05 PM |
Legault Pierre | Director | Aug 05, 2022 | Sale | $23.02 | 24,000 | 552,382 | 32,000 | Aug 09, 2022, 04:05 PM |
Metzger Michael A | Chief Executive Officer | Jul 25, 2022 | Option Exercise | $6.38 | 31,602 | 201,621 | 37,423 | Jul 27, 2022, 06:42 PM |
Metzger Michael A | Chief Executive Officer | Jul 25, 2022 | Sale | $21.06 | 31,602 | 665,393 | 17,659 | Jul 27, 2022, 06:42 PM |
Metzger Michael A | Chief Executive Officer | Jul 07, 2022 | Option Exercise | $6.38 | 100 | 638 | 17,759 | Jul 08, 2022, 05:51 PM |
Metzger Michael A | Chief Executive Officer | Jul 06, 2022 | Option Exercise | $6.38 | 15,009 | 95,757 | 32,668 | Jul 08, 2022, 05:51 PM |
Metzger Michael A | Chief Executive Officer | Jul 07, 2022 | Sale | $21.00 | 100 | 2,100 | 17,659 | Jul 08, 2022, 05:51 PM |
Metzger Michael A | Chief Executive Officer | Jul 06, 2022 | Sale | $21.07 | 15,009 | 316,307 | 17,659 | Jul 08, 2022, 05:51 PM |
Morrison Briggs | President, Head of R&D | Apr 01, 2022 | Option Exercise | $7.20 | 70,545 | 507,924 | 88,381 | Apr 13, 2022, 04:09 PM |
Morrison Briggs | President, Head of R&D | Apr 04, 2022 | Option Exercise | $7.20 | 3,128 | 22,522 | 20,964 | Apr 13, 2022, 04:09 PM |
Morrison Briggs | President, Head of R&D | Apr 04, 2022 | Option Exercise | $10.90 | 3,128 | 34,095 | 20,964 | Apr 05, 2022, 04:05 PM |
Morrison Briggs | President, Head of R&D | Apr 01, 2022 | Option Exercise | $10.90 | 70,545 | 768,940 | 88,381 | Apr 05, 2022, 04:05 PM |
Morrison Briggs | President, Head of R&D | Apr 04, 2022 | Sale | $18.29 | 3,128 | 57,220 | 17,836 | Apr 05, 2022, 04:05 PM |
Morrison Briggs | President, Head of R&D | Apr 01, 2022 | Sale | $17.45 | 101,045 | 1,763,515 | 42,336 | Apr 05, 2022, 04:05 PM |
Ordentlich Peter | Chief Scientific Officer | Jan 31, 2022 | Option Exercise | $12.39 | 1,412 | 17,495 | 1,412 | Feb 03, 2022, 05:32 PM |
Ordentlich Peter | Chief Scientific Officer | Feb 01, 2022 | Sale | $16.65 | 1,412 | 23,510 | 0 | Feb 03, 2022, 05:32 PM |
Meyers Michael L. | SVP, Chief Medical Officer | Jan 31, 2022 | Option Exercise | $12.39 | 1,714 | 21,236 | 23,280 | Feb 03, 2022, 05:31 PM |
Nolte Alexander | Chief Accounting Officer | Jan 31, 2022 | Option Exercise | $12.39 | 968 | 11,994 | 968 | Feb 03, 2022, 05:31 PM |
Nolte Alexander | Chief Accounting Officer | Feb 01, 2022 | Sale | $16.65 | 968 | 16,117 | 0 | Feb 03, 2022, 05:31 PM |
Meyers Michael L. | SVP, Chief Medical Officer | Dec 30, 2021 | Option Exercise | $8.77 | 5,900 | 51,743 | 21,566 | Jan 03, 2022, 04:03 PM |
Legault Pierre | Director | Dec 20, 2021 | Option Exercise | $7.08 | 20,000 | 141,600 | 36,000 | Dec 22, 2021, 06:25 PM |
Legault Pierre | Director | Dec 22, 2021 | Option Exercise | $7.88 | 24,000 | 189,120 | 40,000 | Dec 22, 2021, 06:25 PM |
Legault Pierre | Director | Dec 20, 2021 | Sale | $21.01 | 20,000 | 420,250 | 16,000 | Dec 22, 2021, 06:25 PM |
Legault Pierre | Director | Dec 22, 2021 | Sale | $22.01 | 24,000 | 528,206 | 16,000 | Dec 22, 2021, 06:25 PM |
Morrison Briggs | Chief Executive Officer | Dec 17, 2021 | Option Exercise | $10.90 | 35,156 | 383,200 | 83,492 | Dec 20, 2021, 06:44 PM |
Morrison Briggs | Chief Executive Officer | Dec 17, 2021 | Sale | $20.00 | 35,156 | 703,120 | 48,336 | Dec 20, 2021, 06:44 PM |
Metzger Michael A | President and COO | Dec 16, 2021 | Option Exercise | $6.38 | 22,715 | 144,922 | 40,374 | Dec 20, 2021, 06:44 PM |
Metzger Michael A | President and COO | Dec 20, 2021 | Option Exercise | $8.14 | 61,000 | 496,730 | 62,659 | Dec 20, 2021, 06:44 PM |
Metzger Michael A | President and COO | Dec 17, 2021 | Option Exercise | $6.38 | 1,676 | 10,693 | 19,335 | Dec 20, 2021, 06:44 PM |
Metzger Michael A | President and COO | Dec 16, 2021 | Sale | $19.08 | 22,715 | 433,400 | 17,659 | Dec 20, 2021, 06:44 PM |
Metzger Michael A | President and COO | Dec 20, 2021 | Sale | $20.29 | 61,000 | 1,237,568 | 17,659 | Dec 20, 2021, 06:44 PM |
Metzger Michael A | President and COO | Dec 17, 2021 | Sale | $19.02 | 1,676 | 31,877 | 17,659 | Dec 20, 2021, 06:44 PM |
Metzger Michael A | President and COO | Dec 13, 2021 | Option Exercise | $6.43 | 36,609 | 235,242 | 52,223 | Dec 15, 2021, 05:35 PM |
Metzger Michael A | President and COO | Dec 13, 2021 | Sale | $19.05 | 36,609 | 697,519 | 17,659 | Dec 15, 2021, 05:35 PM |
Egros Fabrice | Director | Nov 18, 2021 | Option Exercise | $8.93 | 14,030 | 125,256 | 30,000 | Nov 19, 2021, 04:06 PM |
Egros Fabrice | Director | Nov 18, 2021 | Sale | $18.03 | 14,030 | 252,993 | 16,000 | Nov 19, 2021, 04:06 PM |
Metzger Michael A | President and COO | Oct 26, 2021 | Option Exercise | $7.20 | 16,296 | 117,331 | 33,955 | Oct 27, 2021, 04:11 PM |
Metzger Michael A | President and COO | Oct 25, 2021 | Option Exercise | $7.20 | 44,704 | 321,869 | 62,363 | Oct 27, 2021, 04:11 PM |
Metzger Michael A | President and COO | Oct 26, 2021 | Sale | $19.20 | 16,296 | 312,825 | 17,659 | Oct 27, 2021, 04:11 PM |
Metzger Michael A | President and COO | Oct 25, 2021 | Sale | $19.13 | 44,704 | 855,335 | 17,659 | Oct 27, 2021, 04:11 PM |
Metzger Michael A | President and COO | Sep 27, 2021 | Option Exercise | $7.20 | 24,437 | 175,946 | 42,096 | Sep 28, 2021, 04:36 PM |
Metzger Michael A | President and COO | Sep 27, 2021 | Sale | $19.51 | 24,437 | 476,832 | 17,659 | Sep 28, 2021, 04:36 PM |
Metzger Michael A | President and COO | Sep 22, 2021 | Option Exercise | $7.20 | 300 | 2,160 | 17,959 | Sep 22, 2021, 04:50 PM |
Metzger Michael A | President and COO | Sep 21, 2021 | Option Exercise | $7.20 | 4,808 | 34,618 | 22,467 | Sep 22, 2021, 04:50 PM |
Metzger Michael A | President and COO | Sep 20, 2021 | Option Exercise | $7.20 | 31,455 | 226,476 | 49,114 | Sep 22, 2021, 04:50 PM |
Metzger Michael A | President and COO | Sep 22, 2021 | Sale | $19.02 | 300 | 5,706 | 17,659 | Sep 22, 2021, 04:50 PM |
Metzger Michael A | President and COO | Sep 21, 2021 | Sale | $19.16 | 4,808 | 92,108 | 17,659 | Sep 22, 2021, 04:50 PM |
Metzger Michael A | President and COO | Sep 20, 2021 | Sale | $19.24 | 31,455 | 605,046 | 17,659 | Sep 22, 2021, 04:50 PM |
Morrison Briggs | Chief Executive Officer | Sep 20, 2021 | Option Exercise | $7.20 | 50 | 360 | 48,386 | Sep 21, 2021, 04:35 PM |
Morrison Briggs | Chief Executive Officer | Sep 17, 2021 | Option Exercise | $7.20 | 70,262 | 505,886 | 118,598 | Sep 21, 2021, 04:35 PM |
Morrison Briggs | Chief Executive Officer | Sep 20, 2021 | Sale | $20.00 | 50 | 1,000 | 48,336 | Sep 21, 2021, 04:35 PM |
Morrison Briggs | Chief Executive Officer | Sep 17, 2021 | Sale | $20.07 | 70,262 | 1,410,018 | 48,336 | Sep 21, 2021, 04:35 PM |
Metzger Michael A | President and COO | Sep 13, 2021 | Option Exercise | $7.20 | 16,651 | 119,887 | 34,310 | Sep 15, 2021, 04:16 PM |
Metzger Michael A | President and COO | Sep 14, 2021 | Option Exercise | $7.20 | 44,349 | 319,313 | 62,008 | Sep 15, 2021, 04:16 PM |
Metzger Michael A | President and COO | Sep 14, 2021 | Sale | $19.15 | 44,349 | 849,394 | 17,659 | Sep 15, 2021, 04:16 PM |
Metzger Michael A | President and COO | Sep 13, 2021 | Sale | $19.02 | 16,651 | 316,639 | 17,659 | Sep 15, 2021, 04:16 PM |
Egros Fabrice | Director | Aug 18, 2021 | Option Exercise | $7.88 | 15,635 | 123,204 | 31,635 | Aug 20, 2021, 04:32 PM |
Egros Fabrice | Director | Aug 18, 2021 | Sale | $15.75 | 15,635 | 246,328 | 16,000 | Aug 20, 2021, 04:32 PM |
Egros Fabrice | Director | May 18, 2021 | Option Exercise | $7.28 | 13,609 | 99,129 | 29,609 | May 20, 2021, 04:46 PM |
Egros Fabrice | Director | May 18, 2021 | Sale | $18.65 | 13,609 | 253,783 | 17,683 | May 20, 2021, 04:46 PM |
Meyers Michael L. | SVP, Chief Medical Officer | Apr 26, 2021 | Buy | $15.46 | 500 | 7,730 | 15,666 | Apr 28, 2021, 04:15 PM |
Podlesak Dennis | Director | Apr 22, 2021 | Buy | $14.11 | 13,967 | 197,077 | 43,300 | Apr 22, 2021, 05:06 PM |
Egros Fabrice | Director | Mar 01, 2021 | Option Exercise | $6.36 | 10,241 | 65,093 | 26,241 | Mar 03, 2021, 04:16 PM |
Egros Fabrice | Director | Mar 01, 2021 | Sale | $24.31 | 10,241 | 248,981 | 16,074 | Mar 03, 2021, 04:16 PM |
Morrison Briggs | Chief Executive Officer | Feb 08, 2021 | Option Exercise | $7.20 | 35,156 | 253,123 | 83,492 | Feb 10, 2021, 04:23 PM |
Morrison Briggs | Chief Executive Officer | Feb 08, 2021 | Sale | $20.55 | 35,156 | 722,403 | 48,336 | Feb 10, 2021, 04:23 PM |
Morrison Briggs | Chief Executive Officer | Jan 31, 2021 | Option Exercise | $12.00 | 1,771 | 21,252 | 48,336 | Feb 05, 2021, 04:21 PM |
Meyers Michael L. | SVP, Chief Medical Officer | Jan 31, 2021 | Option Exercise | $12.00 | 1,771 | 21,252 | 15,166 | Feb 05, 2021, 04:21 PM |
Meyers Michael L. | SVP, Chief Medical Officer | Jul 31, 2020 | Option Exercise | $7.97 | 2,665 | 21,240 | 13,395 | Feb 05, 2021, 04:21 PM |
Metzger Michael A | President and COO | Feb 01, 2021 | Option Exercise | $7.20 | 15,000 | 108,000 | 32,659 | Feb 03, 2021, 05:53 PM |
Metzger Michael A | President and COO | Feb 01, 2021 | Sale | $20.19 | 15,000 | 302,799 | 17,659 | Feb 03, 2021, 05:53 PM |
Metzger Michael A | President and COO | Dec 01, 2020 | Option Exercise | $7.20 | 15,000 | 108,000 | 32,659 | Dec 03, 2020, 06:05 PM |
Metzger Michael A | President and COO | Dec 01, 2020 | Sale | $22.97 | 15,000 | 344,513 | 17,659 | Dec 03, 2020, 06:05 PM |
Ordentlich Peter | Chief Scientific Officer | Nov 23, 2020 | Option Exercise | $3.08 | 29,972 | 92,314 | 29,972 | Nov 25, 2020, 04:38 PM |
Ordentlich Peter | Chief Scientific Officer | Nov 23, 2020 | Sale | $23.16 | 29,972 | 694,121 | 24,288 | Nov 25, 2020, 04:38 PM |
Morrison Briggs | Chief Executive Officer | Nov 10, 2020 | Option Exercise | $7.20 | 17,466 | 125,755 | 64,031 | Nov 12, 2020, 05:55 PM |
Morrison Briggs | Chief Executive Officer | Nov 09, 2020 | Option Exercise | $7.20 | 62,938 | 453,154 | 109,503 | Nov 12, 2020, 05:55 PM |
Morrison Briggs | Chief Executive Officer | Nov 10, 2020 | Sale | $20.06 | 17,466 | 350,312 | 46,565 | Nov 12, 2020, 05:55 PM |
Morrison Briggs | Chief Executive Officer | Nov 09, 2020 | Sale | $20.04 | 62,938 | 1,261,265 | 46,565 | Nov 12, 2020, 05:55 PM |
Metzger Michael A | President and COO | Nov 04, 2020 | Option Exercise | $7.20 | 100,000 | 720,000 | 117,659 | Nov 06, 2020, 05:55 PM |
Metzger Michael A | President and COO | Nov 04, 2020 | Sale | $20.31 | 100,000 | 2,031,410 | 17,659 | Nov 06, 2020, 05:55 PM |
Shea Richard P | Chief Financial Officer | Jan 31, 2020 | Option Exercise | $7.97 | 1,505 | 11,995 | 7,121 | Feb 14, 2020, 04:37 PM |
Shea Richard P | Chief Financial Officer | Jul 31, 2019 | Option Exercise | $4.89 | 1,401 | 6,851 | 5,616 | Feb 14, 2020, 04:37 PM |
Morrison Briggs | Chief Executive Officer | Feb 04, 2020 | Buy | $8.00 | 12,500 | 100,000 | 43,900 | Feb 05, 2020, 04:07 PM |
Morrison Briggs | Chief Executive Officer | Oct 10, 2019 | Buy | $5.40 | 11,000 | 59,400 | 31,400 | Oct 11, 2019, 06:33 AM |
Morrison Briggs | Chief Executive Officer | May 13, 2019 | Buy | $7.29 | 7,200 | 52,517 | 20,400 | May 13, 2019, 04:11 PM |
Morrison Briggs | Chief Executive Officer | May 09, 2019 | Buy | $7.55 | 13,200 | 99,726 | 13,200 | May 13, 2019, 04:11 PM |
Meyers Michael L. | SVP, Chief Medical Officer | Mar 21, 2019 | Buy | $4.87 | 8 | 39 | 7,230 | Mar 25, 2019, 04:03 PM |
Meyers Michael L. | SVP, Chief Medical Officer | Mar 21, 2019 | Buy | $4.92 | 1,104 | 5,436 | 7,222 | Mar 22, 2019, 04:05 PM |
Shea Richard P | Chief Financial Officer | Jan 31, 2019 | Option Exercise | $4.76 | 2,521 | 12,000 | 4,215 | Feb 08, 2019, 04:27 PM |
Meyers Michael L. | SVP, Chief Medical Officer | Jan 31, 2019 | Option Exercise | $4.76 | 3,720 | 17,707 | 6,118 | Feb 08, 2019, 04:27 PM |
Metzger Michael A | President and COO | Jan 31, 2019 | Option Exercise | $4.76 | 2,659 | 12,657 | 2,659 | Feb 08, 2019, 04:27 PM |
Meyers Michael L. | SVP, Chief Medical Officer | Oct 30, 2018 | Buy | $4.79 | 200 | 958 | 2,398 | Nov 07, 2018, 04:02 PM |
Ordentlich Peter | Chief Scientific Officer | Apr 03, 2018 | Option Exercise | $3.08 | 7,500 | 23,100 | 7,500 | Apr 03, 2018, 04:42 PM |
Ordentlich Peter | Chief Scientific Officer | Apr 03, 2018 | Sale | $15.00 | 7,500 | 112,500 | 0 | Apr 03, 2018, 04:42 PM |
Ordentlich Peter | Chief Scientific Officer | May 17, 2017 | Option Exercise | $3.08 | 732 | 2,255 | 5,000 | May 19, 2017, 11:27 AM |
Ordentlich Peter | Chief Scientific Officer | May 17, 2017 | Sale | $15.00 | 5,000 | 75,000 | 0 | May 19, 2017, 11:27 AM |
ROYSTON IVOR | Director | Mar 20, 2017 | Option Exercise | $13.75 | 125,000 | 1,718,750 | 625,545 | Mar 22, 2017, 01:37 PM |
ROYSTON IVOR | Director | Mar 08, 2016 | Buy | $12.00 | 150,000 | 1,800,000 | 750,545 | Mar 08, 2016, 06:38 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Goldan Keith A. | Chief Financial Officer | 01/31/2024 | 20,608 |
Goldan Keith A. | Chief Financial Officer | 07/31/2023 | 15,619 |
Morrison Briggs | Director | 08/09/2023 | 463,538 |
Morrison Briggs | Director | 08/09/2023 | 965,402 |
Meury William | Director | 08/02/2023 | 665,250 |
Meury William | Director | 08/02/2023 | 1,697,810 |
Morrison Briggs | Director | 07/10/2023 | 463,538 |
Morrison Briggs | Director | 07/10/2023 | 1,078,068 |
Goldan Keith A. | Chief Financial Officer | 06/13/2023 | 12,873 |
Morrison Briggs | Director | 06/09/2023 | 404,787 |
Morrison Briggs | Director | 06/09/2023 | 1,119,421 |
Morrison Briggs | Director | 05/09/2023 | 337,215 |
Morrison Briggs | Director | 05/09/2023 | 1,131,478 |
Morrison Briggs | Director | 04/10/2023 | 337,215 |
Morrison Briggs | Director | 04/10/2023 | 1,032,237 |
Morrison Briggs | President, Head of R&D | 03/13/2023 | 337,209 |
Morrison Briggs | President, Head of R&D | 03/13/2023 | 1,190,674 |
Ordentlich Peter | Chief Scientific Officer | 02/15/2023 | 173,791 |
Ordentlich Peter | Chief Scientific Officer | 02/15/2023 | 646,093 |
Metzger Michael A | Chief Executive Officer | 02/06/2023 | 38,018 |
Metzger Michael A | Chief Executive Officer | 02/06/2023 | 164,697 |
Morrison Briggs | President, Head of R&D | 02/06/2023 | 337,209 |
Morrison Briggs | President, Head of R&D | 02/06/2023 | 1,417,909 |
Ordentlich Peter | Chief Scientific Officer | 01/31/2023 | 1,195 |
Ordentlich Peter | Chief Scientific Officer | 02/01/2023 | 1,962 |
Legault Pierre | Director | 01/13/2023 | 203,700 |
Legault Pierre | Director | 01/12/2023 | 227,280 |
Legault Pierre | Director | 01/13/2023 | 405,000 |
Legault Pierre | Director | 01/12/2023 | 641,782 |
Ordentlich Peter | Chief Scientific Officer | 12/02/2022 | 109,736 |
Ordentlich Peter | Chief Scientific Officer | 12/01/2022 | 49,651 |
Ordentlich Peter | Chief Scientific Officer | 12/02/2022 | 430,936 |
Ordentlich Peter | Chief Scientific Officer | 12/01/2022 | 195,089 |
Katkin Keith | Director | 10/06/2022 | 245,177 |
Katkin Keith | Director | 10/06/2022 | 774,411 |
Metzger Michael A | Chief Executive Officer | 10/06/2022 | 142,346 |
Metzger Michael A | Chief Executive Officer | 10/06/2022 | 410,508 |
Metzger Michael A | Chief Executive Officer | 10/04/2022 | 11,226 |
Metzger Michael A | Chief Executive Officer | 10/03/2022 | 25,284 |
Metzger Michael A | Chief Executive Officer | 09/30/2022 | 259,645 |
Metzger Michael A | Chief Executive Officer | 10/04/2022 | 32,026 |
Metzger Michael A | Chief Executive Officer | 10/03/2022 | 72,107 |
Metzger Michael A | Chief Executive Officer | 09/30/2022 | 740,757 |
Katkin Keith | Director | 10/04/2022 | 3,071 |
Katkin Keith | Director | 10/03/2022 | 1,432 |
Katkin Keith | Director | 09/30/2022 | 28,740 |
Katkin Keith | Director | 10/04/2022 | 9,000 |
Katkin Keith | Director | 10/03/2022 | 4,500 |
Katkin Keith | Director | 09/30/2022 | 89,277 |
Morrison Briggs | President, Head of R&D | 09/20/2022 | 650,174 |
Morrison Briggs | President, Head of R&D | 09/19/2022 | 1,246,295 |
Morrison Briggs | President, Head of R&D | 09/20/2022 | 1,387,012 |
Morrison Briggs | President, Head of R&D | 09/19/2022 | 2,633,044 |
Morrison Briggs | President, Head of R&D | 09/14/2022 | 631,044 |
Morrison Briggs | President, Head of R&D | 09/16/2022 | 1,096,226 |
Morrison Briggs | President, Head of R&D | 09/15/2022 | 480,780 |
Morrison Briggs | President, Head of R&D | 09/16/2022 | 2,902,437 |
Morrison Briggs | President, Head of R&D | 09/15/2022 | 1,616,035 |
Morrison Briggs | President, Head of R&D | 09/14/2022 | 2,085,855 |
Podlesak Dennis | Director | 09/15/2022 | 422,429 |
Podlesak Dennis | Director | 09/16/2022 | 75,879 |
Podlesak Dennis | Director | 09/16/2022 | 280,607 |
Podlesak Dennis | Director | 09/15/2022 | 1,617,381 |
Ordentlich Peter | Chief Scientific Officer | 07/29/2022 | 3,742 |
Ordentlich Peter | Chief Scientific Officer | 08/24/2022 | 158,065 |
Ordentlich Peter | Chief Scientific Officer | 08/24/2022 | 625,892 |
Legault Pierre | Director | 08/05/2022 | 221,320 |
Legault Pierre | Director | 08/05/2022 | 552,382 |
Metzger Michael A | Chief Executive Officer | 07/25/2022 | 201,621 |
Metzger Michael A | Chief Executive Officer | 07/25/2022 | 665,393 |
Metzger Michael A | Chief Executive Officer | 07/07/2022 | 638 |
Metzger Michael A | Chief Executive Officer | 07/06/2022 | 95,757 |
Metzger Michael A | Chief Executive Officer | 07/07/2022 | 2,100 |
Metzger Michael A | Chief Executive Officer | 07/06/2022 | 316,307 |
Morrison Briggs | President, Head of R&D | 04/01/2022 | 507,924 |
Morrison Briggs | President, Head of R&D | 04/04/2022 | 22,522 |
Morrison Briggs | President, Head of R&D | 04/04/2022 | 34,095 |
Morrison Briggs | President, Head of R&D | 04/01/2022 | 768,940 |
Morrison Briggs | President, Head of R&D | 04/04/2022 | 57,220 |
Morrison Briggs | President, Head of R&D | 04/01/2022 | 1,763,515 |
Ordentlich Peter | Chief Scientific Officer | 01/31/2022 | 17,495 |
Ordentlich Peter | Chief Scientific Officer | 02/01/2022 | 23,510 |
Meyers Michael L. | SVP, Chief Medical Officer | 01/31/2022 | 21,236 |
Nolte Alexander | Chief Accounting Officer | 01/31/2022 | 11,994 |
Nolte Alexander | Chief Accounting Officer | 02/01/2022 | 16,117 |
Meyers Michael L. | SVP, Chief Medical Officer | 12/30/2021 | 51,743 |
Legault Pierre | Director | 12/20/2021 | 141,600 |
Legault Pierre | Director | 12/22/2021 | 189,120 |
Legault Pierre | Director | 12/20/2021 | 420,250 |
Legault Pierre | Director | 12/22/2021 | 528,206 |
Morrison Briggs | Chief Executive Officer | 12/17/2021 | 383,200 |
Morrison Briggs | Chief Executive Officer | 12/17/2021 | 703,120 |
Metzger Michael A | President and COO | 12/16/2021 | 144,922 |
Metzger Michael A | President and COO | 12/20/2021 | 496,730 |
Metzger Michael A | President and COO | 12/17/2021 | 10,693 |
Metzger Michael A | President and COO | 12/16/2021 | 433,400 |
Metzger Michael A | President and COO | 12/20/2021 | 1,237,568 |
Metzger Michael A | President and COO | 12/17/2021 | 31,877 |
Metzger Michael A | President and COO | 12/13/2021 | 235,242 |
Metzger Michael A | President and COO | 12/13/2021 | 697,519 |
Egros Fabrice | Director | 11/18/2021 | 125,256 |
Egros Fabrice | Director | 11/18/2021 | 252,993 |
Metzger Michael A | President and COO | 10/26/2021 | 117,331 |
Metzger Michael A | President and COO | 10/25/2021 | 321,869 |
Metzger Michael A | President and COO | 10/26/2021 | 312,825 |
Metzger Michael A | President and COO | 10/25/2021 | 855,335 |
Metzger Michael A | President and COO | 09/27/2021 | 175,946 |
Metzger Michael A | President and COO | 09/27/2021 | 476,832 |
Metzger Michael A | President and COO | 09/22/2021 | 2,160 |
Metzger Michael A | President and COO | 09/21/2021 | 34,618 |
Metzger Michael A | President and COO | 09/20/2021 | 226,476 |
Metzger Michael A | President and COO | 09/22/2021 | 5,706 |
Metzger Michael A | President and COO | 09/21/2021 | 92,108 |
Metzger Michael A | President and COO | 09/20/2021 | 605,046 |
Morrison Briggs | Chief Executive Officer | 09/20/2021 | 360 |
Morrison Briggs | Chief Executive Officer | 09/17/2021 | 505,886 |
Morrison Briggs | Chief Executive Officer | 09/20/2021 | 1,000 |
Morrison Briggs | Chief Executive Officer | 09/17/2021 | 1,410,018 |
Metzger Michael A | President and COO | 09/13/2021 | 119,887 |
Metzger Michael A | President and COO | 09/14/2021 | 319,313 |
Metzger Michael A | President and COO | 09/14/2021 | 849,394 |
Metzger Michael A | President and COO | 09/13/2021 | 316,639 |
Egros Fabrice | Director | 08/18/2021 | 123,204 |
Egros Fabrice | Director | 08/18/2021 | 246,328 |
Egros Fabrice | Director | 05/18/2021 | 99,129 |
Egros Fabrice | Director | 05/18/2021 | 253,783 |
Meyers Michael L. | SVP, Chief Medical Officer | 04/26/2021 | 7,730 |
Podlesak Dennis | Director | 04/22/2021 | 197,077 |
Egros Fabrice | Director | 03/01/2021 | 65,093 |
Egros Fabrice | Director | 03/01/2021 | 248,981 |
Morrison Briggs | Chief Executive Officer | 02/08/2021 | 253,123 |
Morrison Briggs | Chief Executive Officer | 02/08/2021 | 722,403 |
Morrison Briggs | Chief Executive Officer | 01/31/2021 | 21,252 |
Meyers Michael L. | SVP, Chief Medical Officer | 01/31/2021 | 21,252 |
Meyers Michael L. | SVP, Chief Medical Officer | 07/31/2020 | 21,240 |
Metzger Michael A | President and COO | 02/01/2021 | 108,000 |
Metzger Michael A | President and COO | 02/01/2021 | 302,799 |
Metzger Michael A | President and COO | 12/01/2020 | 108,000 |
Metzger Michael A | President and COO | 12/01/2020 | 344,513 |
Ordentlich Peter | Chief Scientific Officer | 11/23/2020 | 92,314 |
Ordentlich Peter | Chief Scientific Officer | 11/23/2020 | 694,121 |
Morrison Briggs | Chief Executive Officer | 11/10/2020 | 125,755 |
Morrison Briggs | Chief Executive Officer | 11/09/2020 | 453,154 |
Morrison Briggs | Chief Executive Officer | 11/10/2020 | 350,312 |
Morrison Briggs | Chief Executive Officer | 11/09/2020 | 1,261,265 |
Metzger Michael A | President and COO | 11/04/2020 | 720,000 |
Metzger Michael A | President and COO | 11/04/2020 | 2,031,410 |
Shea Richard P | Chief Financial Officer | 01/31/2020 | 11,995 |
Shea Richard P | Chief Financial Officer | 07/31/2019 | 6,851 |
Morrison Briggs | Chief Executive Officer | 02/04/2020 | 100,000 |
Morrison Briggs | Chief Executive Officer | 10/10/2019 | 59,400 |
Morrison Briggs | Chief Executive Officer | 05/13/2019 | 52,517 |
Morrison Briggs | Chief Executive Officer | 05/09/2019 | 99,726 |
Meyers Michael L. | SVP, Chief Medical Officer | 03/21/2019 | 39 |
Meyers Michael L. | SVP, Chief Medical Officer | 03/21/2019 | 5,436 |
Shea Richard P | Chief Financial Officer | 01/31/2019 | 12,000 |
Meyers Michael L. | SVP, Chief Medical Officer | 01/31/2019 | 17,707 |
Metzger Michael A | President and COO | 01/31/2019 | 12,657 |
Meyers Michael L. | SVP, Chief Medical Officer | 10/30/2018 | 958 |
Ordentlich Peter | Chief Scientific Officer | 04/03/2018 | 23,100 |
Ordentlich Peter | Chief Scientific Officer | 04/03/2018 | 112,500 |
Ordentlich Peter | Chief Scientific Officer | 05/17/2017 | 2,255 |
Ordentlich Peter | Chief Scientific Officer | 05/17/2017 | 75,000 |
ROYSTON IVOR | Director | 03/20/2017 | 1,718,750 |
ROYSTON IVOR | Director | 03/08/2016 | 1,800,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN SYNDAX PHARMACEUTICALS INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 7,015,548 | 0.00387% | 19.26% | Other |
ORBIMED ADVISORS LLC | 1,749,000 | 0.75% | 36.21% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 1,535,055 | 0.00347% | 12.8% | Other |
CANDRIAM S.C.A. | 1,021,032 | 0.15% | 325.41% | Other |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 900,000 | 0.04% | -10% | Other |
PALO ALTO INVESTORS LP | 472,600 | 0.92% | No change | Other |
RENAISSANCE TECHNOLOGIES LLC | 218,300 | 0.0054% | Exited | Other |
BALYASNY ASSET MANAGEMENT L.P. | 165,018 | 0.0067% | 11.11% | Event Driven |
D. E. SHAW & CO., INC. | 41,965 | 0.00079% | -71.75% | Other |
UBS OCONNOR LLC | 95,949 | 0.15% | New | Value |
UBS OCONNOR LLC | 75,000 (Call) | 0.02% | -6.25% | Value |
TUDOR INVESTMENT CORP ET AL | 68,981 | 0.01% | 130.41% | Event Driven, Other |
ALPS ADVISORS INC | 48,126 | 0.00818% | -6.07% | Other |
AQR CAPITAL MANAGEMENT LLC | 35,902 | 0.00146% | 46.11% | Other |
FARALLON CAPITAL MANAGEMENT LLC | 10,000 | 0.00107% | New | Event Driven, Value |
FISHER ASSET MANAGEMENT, LLC | 147 | 0% | Exited | Other |
CHANGE IN SHARES OUTSTANDING FOR SYNDAX PHARMACEUTICALS INC
STOCK BUYBACKS FOR SYNDAX PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
3.85%
1Q
06/30/2023
4.17%
2Q
03/31/2023
4.47%
3Q
12/31/2022
14.75%
4Q
09/30/2022
19.57%
5Q
06/30/2022
20.59%
6Q
03/31/2022
23.00%
7Q
12/31/2021
22.09%
8Q
09/30/2021
39.61%
9Q
06/30/2021
40.58%
10Q
03/31/2021
40.86%
11Q
12/31/2020
57.40%
12Q
09/30/2020
64.29%
13Q
06/30/2020
78.64%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR SYNDAX PHARMACEUTICALS INC
LOADING...